Literature DB >> 29728796

The Cost-Effectiveness of the Kiva Antibullying Program: Results from a Decision-Analytic Model.

Mattias Persson1, Linn Wennberg2, Linda Beckman3, Christina Salmivalli4, Mikael Svensson5.   

Abstract

Bullying causes substantial suffering for children and adolescents. A number of bullying prevention programs have been advocated as effective methods for counteracting school bullying. However, there is a lack of economic evaluations of bullying prevention programs assessing the "value for money." The aim of this study was to assess the cost-effectiveness of the Finnish bullying prevention program KiVa in comparison to "status quo" (treatment as usual) in a Swedish elementary school setting (grades 1 to 9). The cost-effectiveness analysis was carried out using a payer perspective based on a Markov cohort model. The costs of the program were measured in Swedish kronor and Euros, and the benefits were measured using two different metrics: (1) the number of victim-free years and (2) the number of quality adjusted life years (QALYs). Data on costs, probability transitions, and health-related quality of life measures were retrieved from published literature. Deterministic and probabilistic sensitivity analyses were carried out to establish the uncertainty of the cost-effectiveness results. The base-case analysis indicated that KiVa leads to an increased cost of €829 for a gain of 0.47 victim-free years per student. In terms of the cost per gained QALY, the results indicated a base-case estimate of €13,823, which may be seen as cost-effective given that it is lower than the typically accepted threshold value in Swedish health policy of around €50,000. Further research is needed to confirm the conclusions of this study, especially regarding the treatment effects of KiVa in different school contexts.

Entities:  

Keywords:  Bullying prevention program; Cost-effectiveness; Decision modeling; KiVa

Mesh:

Year:  2018        PMID: 29728796     DOI: 10.1007/s11121-018-0893-6

Source DB:  PubMed          Journal:  Prev Sci        ISSN: 1389-4986


  16 in total

1.  The estimation of a preference-based measure of health from the SF-36.

Authors:  John Brazier; Jennifer Roberts; Mark Deverill
Journal:  J Health Econ       Date:  2002-03       Impact factor: 3.883

2.  Swedish population health-related quality of life results using the EQ-5D.

Authors:  K Burström; M Johannesson; F Diderichsen
Journal:  Qual Life Res       Date:  2001       Impact factor: 4.147

3.  The cost-effectiveness of the Olweus Bullying Prevention Program: Results from a modelling study.

Authors:  Linda Beckman; Mikael Svensson
Journal:  J Adolesc       Date:  2015-09-30

4.  Preference-based health-related quality of life among victims of bullying.

Authors:  Linda Beckman; Mikael Svensson; Ann Frisén
Journal:  Qual Life Res       Date:  2015-08-14       Impact factor: 4.147

5.  The differential impacts of episodic, chronic, and cumulative physical bullying and cyberbullying: the effects of victimization on the school experiences, social support, and mental health of rural adolescents.

Authors:  Paul R Smokowski; Caroline B R Evans; Katie L Cotter
Journal:  Violence Vict       Date:  2014

Review 6.  Recommendations for reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in Health and Medicine.

Authors:  J E Siegel; M C Weinstein; L B Russell; M R Gold
Journal:  JAMA       Date:  1996 Oct 23-30       Impact factor: 56.272

7.  Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-6.

Authors:  Andrew H Briggs; Milton C Weinstein; Elisabeth A L Fenwick; Jonathan Karnon; Mark J Sculpher; A David Paltiel
Journal:  Med Decis Making       Date:  2012 Sep-Oct       Impact factor: 2.583

8.  The KiVa antibullying curriculum and outcome: does fidelity matter?

Authors:  Anne Haataja; Marinus Voeten; Aaron J Boulton; Annarilla Ahtola; Elisa Poskiparta; Christina Salmivalli
Journal:  J Sch Psychol       Date:  2014-08-22

9.  Cross-national time trends in bullying victimization in 33 countries among children aged 11, 13 and 15 from 2002 to 2010.

Authors:  Kayleigh L Chester; Mary Callaghan; Alina Cosma; Peter Donnelly; Wendy Craig; Sophie Walsh; Michal Molcho
Journal:  Eur J Public Health       Date:  2015-04       Impact factor: 3.367

10.  Adult health outcomes of childhood bullying victimization: evidence from a five-decade longitudinal British birth cohort.

Authors:  Ryu Takizawa; Barbara Maughan; Louise Arseneault
Journal:  Am J Psychiatry       Date:  2014-07       Impact factor: 18.112

View more
  5 in total

Review 1.  Systematic Review of Violence Prevention Economic Evaluations, 2000-2019.

Authors:  Cora Peterson; Megan C Kearns
Journal:  Am J Prev Med       Date:  2021-02-16       Impact factor: 5.043

2.  Modelling in economic evaluation of mental health prevention: current status and quality of studies.

Authors:  Nguyen Thu Ha; Nguyen Thanh Huong; Vu Nguyen Anh; Nguyen Quynh Anh
Journal:  BMC Health Serv Res       Date:  2022-07-13       Impact factor: 2.908

3.  Do Neighbors Have More Peaceful Students? Youth Violence Profiles among Adolescents in the Czech Republic, Hungary, Poland, and Slovakia.

Authors:  Dóra Eszter Várnai; Marta Malinowska-Cieślik; Andrea Madarasová Gecková; Ladislav Csémy; Zsolt Horváth
Journal:  Int J Environ Res Public Health       Date:  2022-06-29       Impact factor: 4.614

4.  The UK stand together trial: protocol for a multicentre cluster randomised controlled trial to evaluate the effectiveness and cost-effectiveness of KiVa to reduce bullying in primary schools.

Authors:  Suzy Clarkson; Lucy Bowes; Elinor Coulman; Matthew R Broome; Rebecca Cannings-John; Joanna M Charles; Rhiannon Tudor Edwards; Tamsin Ford; Richard P Hastings; Rachel Hayes; Paul Patterson; Jeremy Segrott; Julia Townson; Richard Watkins; Julia Badger; Judy Hutchings
Journal:  BMC Public Health       Date:  2022-03-29       Impact factor: 3.295

5.  The Effectiveness of the KiVa Bullying Prevention Program in Wales, UK: Results from a Pragmatic Cluster Randomized Controlled Trial.

Authors:  Nick Axford; Gretchen Bjornstad; Suzy Clarkson; Obioha C Ukoumunne; Zoe Wrigley; Justin Matthews; Vashti Berry; Judy Hutchings
Journal:  Prev Sci       Date:  2020-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.